Perspective Therapeutics (CATX) Other Accumulated Expenses (2011 - 2023)

Perspective Therapeutics (CATX) has 13 years of Other Accumulated Expenses data on file, last reported at $480000.0 in Q4 2023.

• For the quarter ending Q4 2023, Other Accumulated Expenses fell 15.94% year-over-year to $480000.0; the trailing twelve-month figure through Dec 2023 stood at $480000.0 (down 15.94% YoY), and the FY2023 full-year result was $480000.0, down 15.94% from the prior year.
• Other Accumulated Expenses grew to $480000.0 in Q4 2023, from $24000.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $571000.0 in Q4 2022 to a low of $15000.0 in Q1 2023.
• A 5-year average of $127300.0 and a median of $96500.0 in 2020 frame the typical range for Other Accumulated Expenses.
• Across the five-year window, Other Accumulated Expenses soared 454.37% in 2022 and sank 84.04% in 2023, its largest moves.
• Tracing CATX's Other Accumulated Expenses over 5 years: stood at $89000.0 in 2019, then gained by 13.48% to $101000.0 in 2020, then grew by 1.98% to $103000.0 in 2021, then soared by 454.37% to $571000.0 in 2022, then retreated by 15.94% to $480000.0 in 2023.
• Business Quant data shows CATX's Other Accumulated Expenses at $480000.0 in Q4 2023, $24000.0 in Q3 2023, and $20000.0 in Q2 2023.